As of 2024-10-13, the Relative Valuation of Charles River Laboratories International Inc (CRL) is 260.59 USD. This relative valuation is based on P/E multiples. With the latest stock price at 192.97 USD, the upside of Charles River Laboratories International Inc based on Relative Valuation is 35.0%.
The range of the Relative Valuation is 249.72 - 283.18 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.9x - 33.9x | 31.7x |
| Forward P/E multiples | 25.8x - 28.5x | 25.9x |
| Fair Price | 249.72 - 283.18 | 260.59 |
| Upside | 29.4% - 46.7% | 35.0% |
| Date | P/E |
| 2024-10-11 | 23.07 |
| 2024-10-10 | 22.89 |
| 2024-10-09 | 22.44 |
| 2024-10-08 | 22.34 |
| 2024-10-07 | 22.63 |
| 2024-10-04 | 22.81 |
| 2024-10-03 | 22.67 |
| 2024-10-02 | 23.07 |
| 2024-10-01 | 23.21 |
| 2024-09-30 | 23.55 |
| 2024-09-27 | 23.71 |
| 2024-09-26 | 23.71 |
| 2024-09-25 | 23.07 |
| 2024-09-24 | 23.99 |
| 2024-09-23 | 24.37 |
| 2024-09-20 | 24.61 |
| 2024-09-19 | 25.06 |
| 2024-09-18 | 24.64 |
| 2024-09-17 | 24.66 |
| 2024-09-16 | 24.36 |
| 2024-09-13 | 23.75 |
| 2024-09-12 | 23.24 |
| 2024-09-11 | 23.15 |
| 2024-09-10 | 22.72 |
| 2024-09-09 | 22.50 |
| 2024-09-06 | 22.47 |
| 2024-09-05 | 22.86 |
| 2024-09-04 | 22.93 |
| 2024-09-03 | 22.96 |
| 2024-08-30 | 23.65 |
| 2024-08-29 | 23.83 |
| 2024-08-28 | 23.55 |
| 2024-08-27 | 24.31 |
| 2024-08-26 | 24.46 |
| 2024-08-23 | 24.54 |
| 2024-08-22 | 24.07 |
| 2024-08-21 | 24.44 |
| 2024-08-20 | 24.21 |
| 2024-08-19 | 24.40 |
| 2024-08-16 | 24.14 |
| 2024-08-15 | 24.16 |
| 2024-08-14 | 23.74 |
| 2024-08-13 | 24.33 |
| 2024-08-12 | 23.23 |
| 2024-08-09 | 24.03 |
| 2024-08-08 | 24.15 |
| 2024-08-07 | 23.91 |
| 2024-08-06 | 27.36 |
| 2024-08-05 | 27.07 |
| 2024-08-02 | 27.93 |